You have 9 free searches left this month | for more free features.

LY2157299

Showing 1 - 21 of 21

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Prostate Cancer Trial in Washington, Chicago, Baltimore (Enzalutamide, LY2157299)

Recruiting
  • Prostate Cancer
  • Washington, District of Columbia
  • +3 more
Jun 1, 2022

Rectal Adenocarcinoma Trial in Portland (LY2157299, Capecitabine, Fluorouracil)

Active, not recruiting
  • Rectal Adenocarcinoma
  • LY2157299
  • +3 more
  • Portland, Oregon
    Providence Cancer Center
Mar 22, 2022

ADVANCED HEPATOCELLULAR CARCINOMA (HCC) Trial in Philadelphia (Galunisertib 150mg by mouth twice a day, Stereotactic Body

Completed
  • ADVANCED HEPATOCELLULAR CARCINOMA (HCC)
  • Galunisertib 150mg by mouth twice a day
  • Stereotactic Body Radiotherapy (SBRT)
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Mar 10, 2022

Glioma Trial in Spain, United States (LY2157299, Lomustine)

Active, not recruiting
  • Glioma
  • Baltimore, Maryland
  • +3 more
Oct 18, 2022

Glioblastoma Trial in Worldwide (LY2157299 monohydrate, Lomustine, Placebo)

Active, not recruiting
  • Glioblastoma
  • LY2157299 monohydrate
  • +2 more
  • Birmingham, Alabama
  • +26 more
Oct 18, 2022

Hepatocellular Carcinoma Trial in Worldwide (LY2157299, Sorafenib, Placebo)

Completed
  • Hepatocellular Carcinoma
  • LY2157299
  • +2 more
  • Beijing, China
  • +15 more
Feb 14, 2022

Metastatic Breast Cancer Trial in New York (Radiation therapy, Study Drug)

Terminated
  • Metastatic Breast Cancer
  • Radiation therapy
  • Study Drug
  • New York, New York
    Weill Cornell Medical College
Nov 20, 2019

Hepatocellular Carcinoma Trial in Chiba, Kanagawa, Suita-shi (LY2157299, Sorafenib)

Completed
  • Hepatocellular Carcinoma
  • Chiba, Japan
  • +2 more
Feb 3, 2020

Carcinoma, Hepatocellular Trial in Worldwide (LY2157299, Sorafenib, Ramucirumab)

Completed
  • Carcinoma, Hepatocellular
  • LY2157299
  • +2 more
  • Fayetteville, Arkansas
  • +39 more
Dec 21, 2020

Metastatic Pancreatic Cancer Trial in Worldwide (Galunisertib, Durvalumab)

Completed
  • Metastatic Pancreatic Cancer
  • Scottsdale, Arizona
  • +10 more
Aug 2, 2019

Colorectal Cancer Metastatic Trial in Amsterdam (Galunisertib)

Withdrawn
  • Colorectal Cancer Metastatic
  • Amsterdam, Noord-Holland, Netherlands
    Antoni van Leeuwenhoek (NKI-AVL)
Jul 22, 2019

MDS Trial in Germany, Italy, Spain (Galunisertib, Placebo)

Completed
  • Myelodysplastic Syndromes
  • Dresden, Germany
  • +13 more
Aug 28, 2019

Myeloproliferative Tumor Trial in New York (Vactosertib)

Recruiting
  • Myeloproliferative Neoplasm
  • New York, New York
    Weill Medical College of Cornell University
Dec 20, 2021

Tumor Trial in New York City (Galunisertib)

Completed
  • Neoplasm
  • New York City, New York
    Memorial Sloan Kettering Cancer Center
Oct 4, 2016

Glioma Trial in Germany, Spain, United States (LY2157299, Radiation, Temozolomide)

Completed
  • Glioma
  • LY2157299
  • +2 more
  • La Jolla, California
  • +9 more
Feb 15, 2017

Healthy Trial in Leeds (Galunisertib)

Completed
  • Healthy
  • Leeds, West Yorkshire, United Kingdom
    For additional information regarding investigative sites for thi
Jun 30, 2016

Pancreatic Tumors Trial in Chiba, Tokyo (LY2157299, Gemcitabine)

Completed
  • Pancreatic Neoplasms
  • Chiba, Japan
  • +1 more
Feb 9, 2016

Tumors, Tumor Metastasis Trial in Tokyo (LY2157299)

Completed
  • Neoplasms
  • Neoplasm Metastasis
  • LY2157299
  • Tokyo, Japan
    For additional information regarding investigative sites for thi
Jun 30, 2014

Healthy Volunteers Trial in Daytona Beach (LY2157299)

Completed
  • Healthy Volunteers
  • LY2157299
  • Daytona Beach, Florida
    For additional information regarding investigative sites for thi
Dec 3, 2013

Healthy Volunteers Trial in Madison ([^14C]-LY2157299)

Completed
  • Healthy Volunteers
  • Madison, Wisconsin
    For additional information regarding investigative sites for thi
Feb 14, 2013